|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medicine, University of Rochester School of Medicine, Rochester, New York
Submitted 12 November 2004 ; accepted in final form 12 August 2005
To assess mechanisms for postprandial hyperglycemia, we used a triple-isotope technique ([\3-3H]glucose and [14C]bicarbonate and oral [6,6-dideutero]glucose iv) and indirect calorimetry to compare components of glucose release and pathways for glucose disposal in 26 subjects with type 2 diabetes and 15 age-, weight-, and sex-matched normal volunteers after a standard meal. The results were as follows: 1) diabetic subjects had greater postprandial glucose release (P < 0.001) because of both increased endogenous and meal-glucose release; 2) the greater endogenous glucose release (P < 0.001) was due to increased gluconeogenesis (P < 0.001) and glycogenolysis (P = 0.01); 3) overall tissue glucose uptake, glycolysis, and storage were comparable in both groups (P > 0.3); 4) glucose clearance (P < 0.001) and oxidation (P = 0.004) were reduced, whereas nonoxidative glycolysis was increased (P = 0.04); and 5) net splanchnic glucose storage was reduced by
45% (P = 0.008) because of increased glycogen cycling (P = 0.03). Thus in type 2 diabetes, postprandial hyperglycemia is primarily due to increased glucose release; hyperglycemia overcomes the effects of impaired insulin secretion and sensitivity on glucose transport, but intracellular defects persist so that pathways of glucose metabolism are abnormal and glucose is shunted away from normal sites of storage (e.g., liver and muscle) into other tissues.
gluconeogenesis; insulin; glycolysis; glycogenolysis; oxidation
This article has been cited by other articles:
![]() |
S.-S. Chen, T. S. Santomango, P. E. Williams, D. B. Lacy, and O. P. McGuinness Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1172 - E1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bokhari, P. Emerson, Z. Israelian, A. Gupta, and C. Meyer Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E440 - E444. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Woerle, M. Albrecht, R. Linke, S. Zschau, C. Neumann, M. Nicolaus, J. E. Gerich, B. Goke, and J. Schirra Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide Diabetes Care, December 1, 2008; 31(12): 2325 - 2331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vinik, A. Nakave, and M. d. P. S. Chuecos A Break in the Brake Mechanism in Diabetes: A cause of postprandial hyperglycemia Diabetes Care, December 1, 2008; 31(12): 2410 - 2413. [Full Text] [PDF] |
||||
![]() |
B. Ravikumar, J. Gerrard, C. Dalla Man, M. J. Firbank, A. Lane, P. T. English, C. Cobelli, and R. Taylor Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content Diabetes, September 1, 2008; 57(9): 2288 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kumashiro, Y. Tamura, T. Uchida, T. Ogihara, Y. Fujitani, T. Hirose, H. Mochizuki, R. Kawamori, and H. Watada Impact of Oxidative Stress and Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} in Hepatic Insulin Resistance Diabetes, August 1, 2008; 57(8): 2083 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Jeoung and R. A. Harris Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E46 - E54. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Woerle, M. Albrecht, R. Linke, S. Zschau, C. Neumann, M. Nicolaus, J. Gerich, B. Goke, and J. Schirra Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E103 - E109. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |